Prohance Side Effects
|
|
Did You Have a Prohance Side Effect? How Effective is Prohance for You? |
Showing 1-25 of 271 Next Page >
Nephrogenic Systemic Fibrosis (8426142-1)
on Jun 06, 2012 Male patient from UNITED STATES , weighting 154.3 lb, was diagnosed with
Patient was taking other medications:
Musculoskeletal Stiffness, Pain, Anxiety, Arthralgia, Skin Hypopigmentation, Skin Fibrosis, Fatigue, Hypoaesthesia, Injury (8388096-6)
Patient was taking Prohance (View Usage). Patient had the following side effects: musculoskeletal stiffness, pain (pain Questions), anxiety (anxiety Questions), arthralgia, skin hypopigmentation, skin fibrosis, fatigue, hypoaesthesia, injury on May 18, 2012 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 170.0 lb, was diagnosed with
Patient was taking other medications:
Bone Pain, Musculoskeletal Chest Pain (8356008-7)
Adverse event was reported on May 11, 2012 by a Male patient taking Prohance (View Usage) (Dosage: N/A) was diagnosed with
Patient was taking other medications:
Shock (8353947-8)
on May 09, 2012 Male patient from JAPAN , 68 years of age, was diagnosed with
Joint Stiffness, Joint Range Of Motion Decreased, Oedema Peripheral, Pruritus, Anxiety, Myalgia, Atrophy, Joint Contracture, Skin Tightness (8351034-6)
on May 04, 2012 Female patient from UNITED STATES , 31 years of age, weighting 131.8 lb, was diagnosed with
Patient was taking other medications:
Circulatory Collapse, Dyspnoea (8345078-8)
Patient was taking Prohance (View Usage). After Prohance was administered, patient had the following side effects: circulatory collapse, dyspnoea on Apr 30, 2012 from GERMANY Additional patient health information: Female patient , 62 years of age, was diagnosed with
Metastasis, Shock (8315380-4)
Adverse event was reported on Apr 20, 2012 by a Female patient taking Prohance (View Usage) (Dosage: N/A) was diagnosed with
Shock (8293745-7)
on Apr 11, 2012 Male patient from JAPAN , 72 years of age, was diagnosed with
Anaphylactoid Reaction, Shock (8266090-3)
on Apr 02, 2012 Female patient from JAPAN , 71 years of age, weighting 116.8 lb, was diagnosed with
Shock (8266019-8)
Patient was taking Prohance (View Usage). Patient experienced the following unwanted or unexpected effects: shock on Apr 02, 2012 from JAPAN Additional patient health information: Male patient , weighting 158.7 lb, was diagnosed with
Dizziness, Shock, Nausea (8265052-X)
Adverse event was reported on Mar 29, 2012 by a Female patient taking Prohance (View Usage) (Dosage: N/A) was diagnosed with
Arrhythmia, Dyspnoea, Neurogenic Shock (8247535-1)
on Mar 26, 2012 Male patient from CANADA , 54 years of age, weighting 198.4 lb, was treated with Prohance (View Usage). After Prohance was administered, patient had the following side effects: arrhythmia (arrhythmia Questions), dyspnoea, neurogenic shock. Prohance dosage: N/A.
Mobility Decreased, Deformity, Oedema Peripheral, Nephrogenic Systemic Fibrosis, Pain, Scar (8221122-3)
on Mar 14, 2012 Male patient from UNITED STATES , weighting 163.8 lb, was diagnosed with
Patient was taking other medications:
Nephrogenic Systemic Fibrosis, Skin Discolouration, Mobility Decreased, Oedema Peripheral, Pain In Extremity, Localised Oedema, Injury, Pruritus, Skin Induration (8217940-8)
Patient was taking Prohance (View Usage). Patient had the following side effects: nephrogenic systemic fibrosis, skin discolouration, mobility decreased, oedema peripheral, pain in extremity, localised oedema, injury, pruritus, skin induration on Mar 12, 2012 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 253.0 lb, was diagnosed with
Patient was taking other medications:
Blood Pressure Decreased, Loss Of Consciousness, Oxygen Saturation Decreased (8179299-4)
Adverse event was reported on Feb 28, 2012 by a Female patient taking Prohance (View Usage) (Dosage: N/A) was diagnosed with
Shock (8178350-5)
on Feb 24, 2012 Male patient from JAPAN , 63 years of age, weighting 167.6 lb, was diagnosed with
Patient was taking other medications:
Anaphylactic Shock (8170015-9)
on Sep 06, 2011 Female patient from UNITED STATES , 68 years of age, weighting 160.9 lb, was diagnosed with
Anaphylactic Reaction (8170014-7)
Patient was taking Prohance (View Usage). After Prohance was administered, patient had the following side effects: anaphylactic reaction on May 05, 2011 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with
Hypersensitivity (8170005-6)
Adverse event was reported on Mar 16, 2011 by a Female patient taking Prohance (View Usage) (Dosage: 10ml Once Intravenous (not Otherwise Specified)) was diagnosed with
Convulsion, Chest Pain, Dyspnoea (8169962-3)
on Apr 07, 2011 Female patient from UNITED STATES , 49 years of age, was diagnosed with
Blood Pressure Decreased (8169918-0)
on Mar 01, 2011 Male patient from UNITED STATES , 69 years of age, weighting 189.6 lb, was diagnosed with
Convulsion (8169917-9)
Patient was taking Prohance (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Jan 26, 2011 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 180.8 lb, was diagnosed with
Patient was taking other medications:
Pruritus, Pharyngeal Oedema, Urticaria, Eyelid Oedema (8169892-7)
Adverse event was reported on Nov 19, 2010 by a Female patient taking Prohance (View Usage) (Dosage: 20ml Once Intravenous (not Otherwise Specified)) was diagnosed with
Unresponsive To Stimuli, Syncope, Feeling Hot (8169857-5)
on Sep 14, 2011 Female patient from UNITED STATES , 74 years of age, weighting 160.9 lb, was diagnosed with
Shock, Dizziness, Nausea (8158392-6)
on Feb 15, 2012 Female patient from JAPAN , 84 years of age, weighting 112.4 lb, was diagnosed with
on Jun 06, 2012 Male patient from UNITED STATES , weighting 154.3 lb, was diagnosed with
- renal mass
Patient was taking other medications:
- PLAVIX (View Plavix Review and Plavix Label )
- OMNISCAN (View Omniscan Review and Omniscan Label )
Musculoskeletal Stiffness, Pain, Anxiety, Arthralgia, Skin Hypopigmentation, Skin Fibrosis, Fatigue, Hypoaesthesia, Injury (8388096-6)
Patient was taking Prohance (View Usage). Patient had the following side effects: musculoskeletal stiffness, pain (pain Questions), anxiety (anxiety Questions), arthralgia, skin hypopigmentation, skin fibrosis, fatigue, hypoaesthesia, injury on May 18, 2012 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 170.0 lb, was diagnosed with
- nuclear magnetic resonance imaging
Patient was taking other medications:
- CYTOXAN (View Cytoxan Review and Cytoxan Label )
- NEPHROVITE [VIT C,VIT H,B5,B12,B9,B3,B6,B2,B1 HCL] (View Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl] Review and Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl] Label )
- PENTAMIDINE ISETHIONATE (View Pentamidine Isethionate Review and Pentamidine Isethionate Label )
- OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label )
- WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label )
- OMNISCAN (Unk, Once) (View Omniscan Review and Omniscan Label )
Bone Pain, Musculoskeletal Chest Pain (8356008-7)
Adverse event was reported on May 11, 2012 by a Male patient taking Prohance (View Usage) (Dosage: N/A) was diagnosed with
- nuclear magnetic resonance imaging
- computerised tomogram
Patient was taking other medications:
- VISIPAQUE (View Visipaque Review and Visipaque Label )
Shock (8353947-8)
on May 09, 2012 Male patient from JAPAN , 68 years of age, was diagnosed with
- nuclear magnetic resonance imaging
- metastasis
Joint Stiffness, Joint Range Of Motion Decreased, Oedema Peripheral, Pruritus, Anxiety, Myalgia, Atrophy, Joint Contracture, Skin Tightness (8351034-6)
on May 04, 2012 Female patient from UNITED STATES , 31 years of age, weighting 131.8 lb, was diagnosed with
- nuclear magnetic resonance imaging
Patient was taking other medications:
- AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label )
- ACCUPRIL (40 Mg Bid) (View Accupril Review and Accupril Label )
- IBUPROFEN (View Ibuprofen Review and Ibuprofen Label )
- RENAGEL (View Renagel Review and Renagel Label )
- CARDURA (View Cardura Review and Cardura Label )
- DEPAKOTE (View Depakote Review and Depakote Label )
- AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label )
- ELAVIL (View Elavil Review and Elavil Label )
Circulatory Collapse, Dyspnoea (8345078-8)
Patient was taking Prohance (View Usage). After Prohance was administered, patient had the following side effects: circulatory collapse, dyspnoea on Apr 30, 2012 from GERMANY Additional patient health information: Female patient , 62 years of age, was diagnosed with
- nuclear magnetic resonance imaging
Metastasis, Shock (8315380-4)
Adverse event was reported on Apr 20, 2012 by a Female patient taking Prohance (View Usage) (Dosage: N/A) was diagnosed with
- diagnostic procedure
- metastasis
Shock (8293745-7)
on Apr 11, 2012 Male patient from JAPAN , 72 years of age, was diagnosed with
- nuclear magnetic resonance imaging
- metastases to central nervous system
- lung neoplasm malignant
Anaphylactoid Reaction, Shock (8266090-3)
on Apr 02, 2012 Female patient from JAPAN , 71 years of age, weighting 116.8 lb, was diagnosed with
- diagnostic procedure
- metastases to central nervous system
Shock (8266019-8)
Patient was taking Prohance (View Usage). Patient experienced the following unwanted or unexpected effects: shock on Apr 02, 2012 from JAPAN Additional patient health information: Male patient , weighting 158.7 lb, was diagnosed with
- diagnostic procedure
- brain cancer metastatic
Dizziness, Shock, Nausea (8265052-X)
Adverse event was reported on Mar 29, 2012 by a Female patient taking Prohance (View Usage) (Dosage: N/A) was diagnosed with
- nuclear magnetic resonance imaging
- ovarian neoplasm
Arrhythmia, Dyspnoea, Neurogenic Shock (8247535-1)
on Mar 26, 2012 Male patient from CANADA , 54 years of age, weighting 198.4 lb, was treated with Prohance (View Usage). After Prohance was administered, patient had the following side effects: arrhythmia (arrhythmia Questions), dyspnoea, neurogenic shock. Prohance dosage: N/A.
Mobility Decreased, Deformity, Oedema Peripheral, Nephrogenic Systemic Fibrosis, Pain, Scar (8221122-3)
on Mar 14, 2012 Male patient from UNITED STATES , weighting 163.8 lb, was diagnosed with
- imaging procedure
Patient was taking other medications:
- METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label )
- FEXOFENADINE HYDROCHLORIDE (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label )
- VENTOLIN HFA (View Ventolin Hfa Review and Ventolin Hfa Label )
- GLIPIZIDE (View Glipizide Review and Glipizide Label )
- SLOW K (View Slow-k Review and Slow-k Label )
- MAGNEVIST (View Magnevist Review and Magnevist Label )
- OPTIMARK (View Optimark Review and Optimark Label )
- AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label )
Nephrogenic Systemic Fibrosis, Skin Discolouration, Mobility Decreased, Oedema Peripheral, Pain In Extremity, Localised Oedema, Injury, Pruritus, Skin Induration (8217940-8)
Patient was taking Prohance (View Usage). Patient had the following side effects: nephrogenic systemic fibrosis, skin discolouration, mobility decreased, oedema peripheral, pain in extremity, localised oedema, injury, pruritus, skin induration on Mar 12, 2012 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 253.0 lb, was diagnosed with
- nuclear magnetic resonance imaging
Patient was taking other medications:
- XOPENEX (View Xopenex Review and Xopenex Label )
- VASOTEC (View Vasotec Review and Vasotec Label )
- DEMEDEX (View Demedex Review and Demedex Label )
- ENALAPRIL (View Enalapril Review and Enalapril Label )
- SENSIPAR (View Sensipar Review and Sensipar Label )
- ASTELIN (View Astelin Review and Astelin Label )
- PHOSLO (View Phoslo Review and Phoslo Label )
- VASOPRESSIN (View Vasopressin Review and Vasopressin Label )
Blood Pressure Decreased, Loss Of Consciousness, Oxygen Saturation Decreased (8179299-4)
Adverse event was reported on Feb 28, 2012 by a Female patient taking Prohance (View Usage) (Dosage: N/A) was diagnosed with
- diagnostic procedure
Shock (8178350-5)
on Feb 24, 2012 Male patient from JAPAN , 63 years of age, weighting 167.6 lb, was diagnosed with
- brain cancer metastatic
- hypertension
Patient was taking other medications:
- NORVASC (View Norvasc Review and Norvasc Label )
- HALCION (View Halcion Review and Halcion Label )
- LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label )
Anaphylactic Shock (8170015-9)
on Sep 06, 2011 Female patient from UNITED STATES , 68 years of age, weighting 160.9 lb, was diagnosed with
- dysphagia
- syncope
- aphasia (aphasia Questions)
- nuclear magnetic resonance imaging brain
- sjogren's syndrome (sjogren's syndrome Questions)
Anaphylactic Reaction (8170014-7)
Patient was taking Prohance (View Usage). After Prohance was administered, patient had the following side effects: anaphylactic reaction on May 05, 2011 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with
- mass
- nuclear magnetic resonance imaging
Hypersensitivity (8170005-6)
Adverse event was reported on Mar 16, 2011 by a Female patient taking Prohance (View Usage) (Dosage: 10ml Once Intravenous (not Otherwise Specified)) was diagnosed with
- adrenal insufficiency
- nuclear magnetic resonance imaging
- fatigue
- headache (headache Questions)
Convulsion, Chest Pain, Dyspnoea (8169962-3)
on Apr 07, 2011 Female patient from UNITED STATES , 49 years of age, was diagnosed with
- mammogram abnormal
- nuclear magnetic resonance imaging
Blood Pressure Decreased (8169918-0)
on Mar 01, 2011 Male patient from UNITED STATES , 69 years of age, weighting 189.6 lb, was diagnosed with
- variant creutzfeldt-jakob disease
- nuclear magnetic resonance imaging
Convulsion (8169917-9)
Patient was taking Prohance (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Jan 26, 2011 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 180.8 lb, was diagnosed with
- nuclear magnetic resonance imaging
Patient was taking other medications:
- MORPHINE (View Morphine Review and Morphine Label )
Pruritus, Pharyngeal Oedema, Urticaria, Eyelid Oedema (8169892-7)
Adverse event was reported on Nov 19, 2010 by a Female patient taking Prohance (View Usage) (Dosage: 20ml Once Intravenous (not Otherwise Specified)) was diagnosed with
- mass
- nuclear magnetic resonance imaging
Unresponsive To Stimuli, Syncope, Feeling Hot (8169857-5)
on Sep 14, 2011 Female patient from UNITED STATES , 74 years of age, weighting 160.9 lb, was diagnosed with
- asthenia
- multiple sclerosis (multiple sclerosis Questions)
- nuclear magnetic resonance imaging
- gait disturbance
Shock, Dizziness, Nausea (8158392-6)
on Feb 15, 2012 Female patient from JAPAN , 84 years of age, weighting 112.4 lb, was diagnosed with
- nuclear magnetic resonance imaging
Showing 1-25 of 271 Next Page >
Prohance Forum
Prohance Adverse Effect Reports (FDA)
Prohance InformationAlternative PROHANCE Names:GADOTERID Substance:GADOTERID Prohance Dosage, Warnings, Usage. Side Effects reported to FDA: 271. View FDA Adverse Reports Prohance safety alerts: 2007 2006 Reported deaths: 26 Reported hospitalizations: 93
| ||||||||